IGFBP6 and autoimmune hepatitis: Recent machine-learning proteomics developed diagnostic panels that distinguish AIH from healthy and MASLD comparators, but IGFBP-6 has not emerged as a consistent component, indicating that if present its contribution may be secondary to dominant immune pathways [69].